Total Payments
$1.1M
2024 Payments
$211,457
Companies
18
Transactions
1,176
Medicare Patients
1,157
Medicare Billing
$273,818
Payment Breakdown by Category
Other$588,621 (51.7%)
Consulting$429,985 (37.7%)
Travel$95,904 (8.4%)
Food & Beverage$24,640 (2.2%)
Education$14.86 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $467,881 | 207 | 41.1% |
| Consulting Fee | $429,985 | 83 | 37.7% |
| Honoraria | $101,300 | 44 | 8.9% |
| Travel and Lodging | $95,904 | 471 | 8.4% |
| Food and Beverage | $24,640 | 359 | 2.2% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $19,440 | 7 | 1.7% |
| Education | $14.86 | 2 | 0.0% |
| Unspecified | $0 | 3 | 0.0% |
Payments by Type
General
$1.1M
1,173 transactions
Ownership
$0
3 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Ceribell, Inc. | $223,116 | 21 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $177,731 | 241 | $0 (2022) |
| UCB, Inc. | $133,246 | 209 | $0 (2024) |
| LivaNova USA, Inc. | $125,882 | 169 | $0 (2024) |
| SK Life Science, Inc. | $111,612 | 124 | $0 (2024) |
| Neurelis, Inc. | $101,652 | 126 | $0 (2024) |
| UCB SA | $72,831 | 75 | $0 (2023) |
| EISAI INC. | $67,141 | 80 | $0 (2022) |
| JAZZ PHARMACEUTICALS INC. | $39,198 | 35 | $0 (2024) |
| Greenwich Biosciences, Inc. | $34,591 | 37 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $211,457 | 137 | Ceribell, Inc. ($111,125) |
| 2023 | $164,839 | 145 | Ceribell, Inc. ($48,671) |
| 2022 | $169,101 | 148 | Ceribell, Inc. ($50,500) |
| 2021 | $85,990 | 73 | SK Life Science, Inc. ($31,748) |
| 2020 | $71,010 | 85 | LivaNova USA, Inc. ($17,055) |
| 2019 | $98,380 | 122 | LivaNova USA, Inc. ($22,010) |
| 2018 | $153,236 | 197 | Sunovion Pharmaceuticals Inc. ($65,641) |
| 2017 | $185,151 | 269 | Sunovion Pharmaceuticals Inc. ($77,126) |
All Payment Transactions
1,176 individual payment records from CMS Open Payments — Page 1 of 48
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Food and Beverage | In-kind items and services | $140.35 | General |
| Category: Neurology | ||||||
| 12/06/2024 | Ceribell, Inc. | POCKET EEG DEVICE (Device) | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| Category: Neurology | ||||||
| 12/06/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $103.25 | General |
| Category: EPILEPSY | ||||||
| 12/05/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $41.24 | General |
| 12/04/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Honoraria | Cash or cash equivalent | $3,500.00 | General |
| Category: Neurology | ||||||
| 12/04/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Food and Beverage | In-kind items and services | $125.93 | General |
| Category: Neurology | ||||||
| 12/04/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Travel and Lodging | Cash or cash equivalent | $14.54 | General |
| Category: Neurology | ||||||
| 11/06/2024 | Ceribell, Inc. | POCKET EEG DEVICE (Device) | Consulting Fee | Cash or cash equivalent | $14,000.00 | General |
| Category: Neurology | ||||||
| 11/01/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Consulting Fee | Cash or cash equivalent | $18,000.00 | General |
| Category: NEUROLOGY | ||||||
| 11/01/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Travel and Lodging | In-kind items and services | $185.00 | General |
| Category: NEUROLOGY | ||||||
| 11/01/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $11.79 | General |
| Category: NEUROLOGY | ||||||
| 11/01/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $10.27 | General |
| Category: NEUROLOGY | ||||||
| 10/29/2024 | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,518.00 | General |
| Category: Neurology | ||||||
| 10/29/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Honoraria | Cash or cash equivalent | $2,800.00 | General |
| Category: Neurology | ||||||
| 10/29/2024 | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) | Travel and Lodging | Cash or cash equivalent | $185.00 | General |
| Category: Neurology | ||||||
| 10/29/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Travel and Lodging | Cash or cash equivalent | $48.91 | General |
| Category: Neurology | ||||||
| 10/29/2024 | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) | Food and Beverage | Cash or cash equivalent | $18.16 | General |
| Category: Neurology | ||||||
| 10/29/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $1.63 | General |
| 10/28/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $38.96 | General |
| 10/17/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Travel and Lodging | In-kind items and services | $259.91 | General |
| Category: NEUROLOGY | ||||||
| 10/16/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Travel and Lodging | In-kind items and services | $173.53 | General |
| Category: NEUROLOGY | ||||||
| 10/16/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: NEUROLOGY | ||||||
| 10/15/2024 | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,518.00 | General |
| Category: Neurology | ||||||
| 10/15/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Travel and Lodging | In-kind items and services | $267.32 | General |
| Category: NEUROLOGY | ||||||
| 10/15/2024 | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) | Travel and Lodging | Cash or cash equivalent | $185.00 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 260 | 502 | $415,325 | $64,811 |
| 2022 | 9 | 305 | 582 | $444,791 | $72,955 |
| 2021 | 8 | 338 | 644 | $495,135 | $84,620 |
| 2020 | 7 | 254 | 423 | $239,120 | $51,433 |
Total Patients
1,157
Total Services
2,151
Medicare Billing
$273,818
Procedure Codes
30
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2023 | 76 | 220 | $212,883 | $37,662 | 17.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 60 | 109 | $104,640 | $14,154 | 13.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 34 | 35 | $46,200 | $5,056 | 10.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 27 | 73 | $34,310 | $4,952 | 14.4% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 49 | 51 | $13,456 | $2,307 | 17.1% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2023 | 14 | 14 | $3,836 | $679.70 | 17.7% |
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2022 | 83 | 261 | $237,249 | $46,309 | 19.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 48 | 86 | $82,560 | $10,713 | 13.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 33 | 87 | $40,890 | $5,270 | 12.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 30 | 31 | $40,920 | $5,059 | 12.4% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 53 | 54 | $13,770 | $2,536 | 18.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 17 | 20 | $17,160 | $1,461 | 8.5% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2022 | 17 | 17 | $4,318 | $846.36 | 19.6% |
| 95822 | Measurement of brain wave activity (eeg), in coma or asleep | Facility | 2022 | 11 | 11 | $2,794 | $546.62 | 19.6% |
| 95970 | Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator | Office | 2022 | 13 | 15 | $5,130 | $213.59 | 4.2% |
| 95720 | Continuous measurement of brain wave activity with video (veeg), 12-26 hours, with health care professional analysis, interpretation and report | Facility | 2021 | 95 | 289 | $262,701 | $51,691 | 19.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 51 | 100 | $96,000 | $13,605 | 14.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 40 | 40 | $52,800 | $6,915 | 13.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 40 | 93 | $43,710 | $5,771 | 13.2% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Facility | 2021 | 71 | 72 | $18,360 | $3,476 | 18.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 13 | 17 | $14,586 | $1,433 | 9.8% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 13 | 18 | $3,168 | $966.07 | 30.5% |
| 95819 | Measurement and recording of brain wave (eeg) activity, awake and asleep | Facility | 2021 | 15 | 15 | $3,810 | $762.60 | 20.0% |
| 95720 | Continuous measurement of brain wave activity with video (veeg), 12-26 hours, with health care professional analysis, interpretation and report | Facility | 2020 | 67 | 180 | $125,100 | $32,521 | 26.0% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 44 | 58 | $37,120 | $5,616 | 15.1% |
About Dr. John Stern, MD
Dr. John Stern, MD is a Clinical Neurophysiology healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1164440442.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Stern, MD has received a total of $1.1M in payments from pharmaceutical and medical device companies, with $211,457 received in 2024. These payments were reported across 1,176 transactions from 18 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($467,881).
As a Medicare-enrolled provider, Stern has provided services to 1,157 Medicare beneficiaries, totaling 2,151 services with total Medicare billing of $273,818. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Ad
Practice Information
- Specialty Clinical Neurophysiology
- Other Specialties Neurology
- Location Los Angeles, CA
- Active Since 07/17/2006
- Last Updated 01/14/2020
- Taxonomy Code 2084N0600X
- Entity Type Individual
- NPI Number 1164440442
Products in Payments
- APTIOM (Drug) $176,628
- POCKET EEG DEVICE (Device) $111,125
- VALTOCO (Drug) $101,652
- XCOPRI (Drug) $97,347
- VNS Therapy (Device) $83,063
- Briviact (Drug) $69,163
- Fycompa (Drug) $67,141
- Ceribell Rapid Response EEG (Device) $61,172
- Rapid Response EEG (Device) $50,500
- Epidiolex (Drug) $34,591
- EPIDIOLEX (Drug) $32,838
- ONFI (Drug) $31,567
- VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) $28,841
- Nayzilam (Drug) $27,737
- Vimpat (Drug) $22,025
- VNS Therapy SenTiva Model 1000 Generator (Device) $14,801
- Cenobamate (Drug) $13,920
- Fintepla (Drug) $11,481
- Aptiom (Drug) $7,696
- VNS - Sentiva (Device) $2,341
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Clinical Neurophysiology Doctors in Los Angeles
Jerome Engel, Md, MD
Clinical Neurophysiology — Payments: $7,616
Clinical Neurophysiology $7,616
Antonio Escueta, Md, MD
Clinical Neurophysiology — Payments: $1,332
Clinical Neurophysiology $1,332
Dr. Rajarshi Mazumder, M.d., M.p.h, M.D., M.P.H
Clinical Neurophysiology — Payments: $1,254
Clinical Neurophysiology $1,254
Dr. Ankit Nayyar, M.d, M.D
Clinical Neurophysiology — Payments: $347.98
Clinical Neurophysiology $347.98
Marc Nuwer, Md, MD
Clinical Neurophysiology — Payments: $341.19
Clinical Neurophysiology $341.19
Dr. David Rosenfeld, M.d, M.D
Clinical Neurophysiology — Payments: $23.31
Clinical Neurophysiology $23.31